Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Journal of Alzheimer's disease : JAD

Volumn 41, Issue 2, 2014, Pages 377-386

  Malaplate Armand, Catherine ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

A rmbeta (_ rm 40 ) peptide; A rmbeta (_ rm 40 ) A rmbeta (_ rm 42 ) ratio; A rmbeta (_ rm 42 ) peptide; Alzheimer's disease; cerebrospinal fluid; diagnosis; differential diagnosis; P tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LEWY BODY DISEASE; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PHOSPHORYLATION; PUNCTURE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SPINAL PUNCTURE; TAU PROTEINS; YOUNG ADULT;

EID: 84920577032     PISSN: None     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131838     Document Type: Article

References (0)